Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1981 Oct;74(2):469–475. doi: 10.1111/j.1476-5381.1981.tb09992.x

Selective inhibition of thromboxane biosynthesis in human blood mononuclear cells and the effects of mitogen-stimulated lymphocyte proliferation.

D Gordon, A M Nouri, R U Thomas
PMCID: PMC2071723  PMID: 7317694

Abstract

1. The effects of six imidazole compounds were examined on thromboxane B2 (TxB2) and prostaglandin E2 (PGE2) production and mitogen-stimulated lymphocyte transformation in human blood mononuclear cells. 2. UK 37248 (4-(2-[IH-imidazol-l-yl]ethoxy)benzoic acid), imidazole and 1-methylimidazole selectively inhibited TxB2 synthesis in a dose-related manner, with corresponding increases in PGE2 production. 3. Clotrimazole, benzimidazole and 2-methylimidazole preferentially inhibited TxB synthesis but had little effect on PGE2 production. 4. Clotrimazole and benzimidazole inhibited proliferative responses of the lymphocytes, but UK 37248 and 1-methylimidazole did not affect transformation at concentrations which inhibited TxB2 synthesis to a similar level (over 90%). 5. The results do not support involvement of endogenous TxB2 in the process of lymphocyte mitogenesis or in the mechanism of the suppressive effects of some TxB2 synthetase inhibitors.

Full text

PDF
469

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bray M. A., Gordon D. Prostaglandin production by macrophages and the effect of anti-inflammatory drugs. Br J Pharmacol. 1978 Aug;63(4):635–642. doi: 10.1111/j.1476-5381.1978.tb17276.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brodie M. J., Hensby C. N., Parke A., Gordon D. Is prostacyclin in the major pro-inflammatory prostanoid in joint fluid? Life Sci. 1980 Aug 18;27(7):603–608. doi: 10.1016/0024-3205(80)90310-0. [DOI] [PubMed] [Google Scholar]
  3. Castor C. W., Ritchie J. C., Scott M. E., Whitney S. L. Connective tissue activation. XI. Stimulation of glycosaminoglycan and DNA formation by a platelet factor. Arthritis Rheum. 1977 Apr;20(3):859–868. doi: 10.1002/art.1780200316. [DOI] [PubMed] [Google Scholar]
  4. Castor C. W., Ritchie J. C., Williams C. H., Jr, Scott M. E., Whitney S. L., Myers S. L., Sloan T. B., Anderson B. E. Connective tissue activation. XIV. Composition and actions of a human platelet autacoid mediator. Arthritis Rheum. 1979 Mar;22(3):260–272. doi: 10.1002/art.1780220308. [DOI] [PubMed] [Google Scholar]
  5. Goodwin J. S., Kaszubowski P. A., Williams R. C., Jr Cyclic adenosine monophosphate response to prostaglandin E2 on subpopulations of human lymphocytes. J Exp Med. 1979 Nov 1;150(5):1260–1264. doi: 10.1084/jem.150.5.1260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Goodwin J. S., Messner R. P., Peake G. T. Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation. J Clin Invest. 1978 Oct;62(4):753–760. doi: 10.1172/JCI109186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gordon D., Henderson D. C., Westwick J. Effects of prostaglandins E2 and I2 on human lymphocyte transformation in the presence and absence of inhibitors of prostaglandin biosynthesis. Br J Pharmacol. 1979 Sep;67(1):17–22. [PMC free article] [PubMed] [Google Scholar]
  8. Hadden J. W., Coffey R. G., Hadden E. M., Lopez-Corrales E., Sunshine G. H. Effects of levamisole and imidazole on lymphocyte proliferation and cyclic nucleotide levels. Cell Immunol. 1975 Nov;20(1):98–103. doi: 10.1016/0008-8749(75)90088-x. [DOI] [PubMed] [Google Scholar]
  9. Hirata F., Toyoshima S., Axelrod J., Waxdal M. J. Phospholipid methylation: a biochemical signal modulating lymphocyte mitogenesis. Proc Natl Acad Sci U S A. 1980 Feb;77(2):862–865. doi: 10.1073/pnas.77.2.862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kelly J. P., Johnson M. C., Parker C. W. Effect of inhibitors of arachidonic acid metabolism on mitogenesis in human lymphocytes: possible role of thromboxanes and products of the lipoxygenase pathway. J Immunol. 1979 Apr;122(4):1563–1571. [PubMed] [Google Scholar]
  11. Kennedy M. S., Stobo J. D., Goldyne M. E. In vitro synthesis of prostaglandins and related lipids by populations of human peripheral blood mononuclear cells. Prostaglandins. 1980 Jul;20(1):135–145. doi: 10.1016/0090-6980(80)90013-1. [DOI] [PubMed] [Google Scholar]
  12. Lum L. G., Benveniste E., Blaese R. M. Functional properties of human T cells bearing Fc receptors for IgA. I. Mitogen responsiveness, mixed lymphocyte culture reactivity, and helper activity for B cell immunoglobulin production. J Immunol. 1980 Feb;124(2):702–707. [PubMed] [Google Scholar]
  13. Miller J. J. The imidazoles as immunosuppressive agents. Transplant Proc. 1980 Jun;12(2):300–303. [PubMed] [Google Scholar]
  14. Moncada S., Bunting S., Mullane K., Thorogood P., Vane J. R., Raz A., Needleman P. Imidazole: a selective inhibitor of thromboxane synthetase. Prostaglandins. 1977 Apr;13(4):611–618. doi: 10.1016/0090-6980(77)90232-5. [DOI] [PubMed] [Google Scholar]
  15. Moretta L., Ferrarini M., Mingari M. C., Moretta A., Webb S. R. Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness. J Immunol. 1976 Dec;117(6):2171–2174. [PubMed] [Google Scholar]
  16. Needleman P., Bryan B., Wyche A., Bronson S. D., Eakins K., Ferrendelli J. A., Minkes M. Thromboxane synthetase inhibitors as pharmacological tools: differential biochemical and biological effects on platelet suspensions. Prostaglandins. 1977 Nov;14(5):897–907. doi: 10.1016/0090-6980(77)90306-9. [DOI] [PubMed] [Google Scholar]
  17. Nicolaou K. C., Magolda R. L., Smith J. B., Aharony D., Smith E. F., Lefer A. M. Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation. Proc Natl Acad Sci U S A. 1979 Jun;76(6):2566–2570. doi: 10.1073/pnas.76.6.2566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Otterness I. G., Niblack J. F. Letter: Clotrimazole and rheumatoid arthritis. Lancet. 1976 Jan 17;1(7951):148–148. doi: 10.1016/s0140-6736(76)93190-1. [DOI] [PubMed] [Google Scholar]
  19. Tyler H. M., Saxton C. A., Parry M. J. Administration to man of UK-37,248-01, a selective inhibitor of thromboxane synthetase. Lancet. 1981 Mar 21;1(8221):629–632. doi: 10.1016/s0140-6736(81)91551-8. [DOI] [PubMed] [Google Scholar]
  20. Wyburn-Mason R. Letter: Clotrimazole and rheumatoid arthritis. Lancet. 1976 Feb 28;1(7957):489–489. doi: 10.1016/s0140-6736(76)91516-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES